Zymeworks ZYME
NASDAQ ZYME
$25.38 -0.58 (-2.23%)
As of: Oct 2, 2026 · 12:45 PM EDT

Zymeworks (ZYME) Other Non Operating Income (2021 - 2022)

Updated

Zymeworks (ZYME) recorded Other Non Operating Income of $1.36 million in Q3 2022, up 67.9% from $809,000 a year earlier.

Analysis

Zymeworks (ZYME) Other Non Operating Income (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Zymeworks 1.89 Bn 775.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 1.36 Mn
Sep 30, 2021 809,000.00
API Access

Zymeworks Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ZYME&period=max&api_key=YOUR_API_KEY